Ibrexafungerp for the Treatment of Complicated Vulvovaginal Candidiasis

Clinical trial NCT05399641 · COMPLETED

Trial details

NCT number: NCT05399641
Sponsor: Scynexis, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Vulvovaginal Candidiasis

Start date: 2022-05-01
Primary completion: 2023-05-16
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.